Malantig, Dianah Jane O.
HRN: 16-26-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 750MG (VIAL)
05/24/2023
05/31/2023
IVT
490mg
Q8
ATP
Checking Final Appropriateness
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes